Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
Presentations
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
Presentations
News
Filter by Year:
2023
2022
2021
2020
27-Sep-2023
Island Pharmaceuticals CEO and Managing Director Dr David Foster on ausbiz
26-Sep-2023
Island Pharma gearing up to start ISLA-101 trial for dengue fever
25-Sep-2023
Island Pharmaceuticals readies for ISLA-101 trial for dengue fever
13-Sep-2023
Island Pharmaceuticals secures key US patent for dengue fever treatment
7-Jul-2023
$US1.3m grant for dengue fever study
6-Jul-2023
Island Pharmaceuticals secures US grant funding to support clinical development of dengue fever candidate
24-May-2023
Island Pharmaceuticals sees tremendous opportunity for mosquito-borne virus program
16-May-2023
Island Pharmaceuticals receives FDA green light for dengue virus ISLA-101 clinical program
17-Apr-2023
Island Pharmaceuticals completes major body of work as it responds to FDA's ISLA-101 requests
9-Feb-2023
Connecting the world to powerful outcomes: Island Pharmaceuticals
1
2
Next
.png){kind=logo}
